HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
COMMON STOCK
8,458
$9.64
$81,535
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Stock Options(Right to buy)
8,458
$9.64
$81,535
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
COMMON STOCK
8,458
$9.64
$81,535
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
195
$9.64
$1,880
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Stock Options (Right to buy)
195
$9.64
$1,880
Sale
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
195
$9.64
$1,880
Option
SIMPSON MICHAEL Sofficer: SVP, Regulatory Affairs and QAofficer: SVP, Regulatory Affair..
Common Stock
79
$16.3
$1,287
Option
DAVIS JOHN Eofficer: Senior VP, Global Salesofficer: Senior VP, Global Sales
Common Stock
922
$16.3
$15,024
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
790
$16.3
$12,873
Option
MAIER DENNIS Bofficer: Vice President, Operationsofficer: Vice President, Operat..
Common Stock
171
$16.3
$2,786
Option
MAIER DENNIS Bofficer: Vice President, Operationsofficer: Vice President, Operat..
ESPP
118
$23.03
$2,717
Option
SIMPSON MICHAEL Sofficer: SVP, Regulatory Affairs and QAofficer: SVP, Regulatory Affair..
ESPP
727
$23.03
$16,741
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
ESPP
356
$23.03
$8,198
Sale
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
3,000
$10.24
$30,720
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Stock Options(Right to buy)
3,000
$10.24
$30,720
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
3,000
$10.24
$30,720
Option
CAPPS SCOTT Bofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
10,000
$6.12
$61,200
Option
CAPPS SCOTT Bofficer: VP, Clinical Researchofficer: VP, Clinical Research
Stock Option (Right to Buy)
10,000
$6.12
$61,200
Sale
CAPPS SCOTT Bofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
7,184
$24.93
$179,111
Sale
MCCALL RONALD Ddirectordirector
Common Stock
4,000
$24.64
$98,564
Purchase
MACKIN JAMES Pofficer: President & CEOofficer: President & CEO
Common Stock
5,000
$23.47
$117,355
Option
MAIER DENNIS Bofficer: Vice President, Operationsofficer: Vice President, Operat..
Common Stock
118
$23.03
$2,717
Option
SIMPSON MICHAEL Sofficer: SVP, Regulatory Affairs and QAofficer: SVP, Regulatory Affair..
Common Stock
727
$23.03
$16,741
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
356
$23.03
$8,198
Option
DAVIS JOHN Eofficer: Senior VP, Global Salesofficer: Senior VP, Global Sales
ESPP
880
$24.12
$21,228
Option
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
ESPP
498
$24.12
$12,013
Option
MAIER DENNIS Bofficer: Vice President, Operationsofficer: Vice President, Operat..
ESPP
108
$24.12
$2,605
Sale
CAPPS SCOTT Bofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
2,000
$28.55
$57,100
Sale
MCCALL RONALD Ddirectordirector
Common Stock
1,563
$28.47
$44,499
Sale
MCCALL RONALD Ddirectordirector
Common Stock
1,000
$28
$28,000
Sale
MCCALL RONALD Ddirectordirector
Common Stock
2,700
$29.02
$78,346
Sale
HOLLOWAY JEAN Fofficer: VP, General Counselofficer: VP, General Counsel
Common Stock
8,654
$9.64
$83,425
Showing 50 to 100 of 657 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.